ATE122680T1 - Stabil fest 2-octynyladenozin und verfahren zu ihrer herstellung. - Google Patents
Stabil fest 2-octynyladenozin und verfahren zu ihrer herstellung.Info
- Publication number
- ATE122680T1 ATE122680T1 AT92102210T AT92102210T ATE122680T1 AT E122680 T1 ATE122680 T1 AT E122680T1 AT 92102210 T AT92102210 T AT 92102210T AT 92102210 T AT92102210 T AT 92102210T AT E122680 T1 ATE122680 T1 AT E122680T1
- Authority
- AT
- Austria
- Prior art keywords
- solid
- octynyladenozin
- production
- alcoholic solution
- octynyl adenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3040894A JP2740362B2 (ja) | 1991-02-12 | 1991-02-12 | 安定な固体状2‐オクチニルアデノシンおよびその製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE122680T1 true ATE122680T1 (de) | 1995-06-15 |
Family
ID=12593220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92102210T ATE122680T1 (de) | 1991-02-12 | 1992-02-10 | Stabil fest 2-octynyladenozin und verfahren zu ihrer herstellung. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5939543A (de) |
| EP (1) | EP0499185B1 (de) |
| JP (1) | JP2740362B2 (de) |
| AT (1) | ATE122680T1 (de) |
| CA (1) | CA2060865C (de) |
| DE (1) | DE69202483T2 (de) |
| ES (1) | ES2073793T3 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
| USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
| US6214807B1 (en) * | 1999-06-22 | 2001-04-10 | Cv Therapeutics, Inc. | C-pyrazole 2A A receptor agonists |
| US6180615B1 (en) * | 1999-06-22 | 2001-01-30 | Cv Therapeutics, Inc. | Propargyl phenyl ether A2A receptor agonists |
| CA2671940A1 (en) * | 2000-02-23 | 2001-08-30 | Cv Therapeutics, Inc. | Identification of partial agonists of the a2a adenosine receptor |
| US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
| NZ537975A (en) * | 2002-07-29 | 2007-08-31 | Cv Therapeutics Inc | Method of producing coronary vasodilation without peripheral vasodilation comprising administering at least 10 mcg of at least one A2A receptor agonist |
| US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
| KR20070083714A (ko) | 2004-10-20 | 2007-08-24 | 씨브이 쎄러퓨틱스, 인코포레이티드 | A2a 아데노신 수용체 작용제의 용도 |
| US7732595B2 (en) | 2006-02-03 | 2010-06-08 | Gilead Palo Alto, Inc. | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
| CA2655310A1 (en) * | 2006-06-22 | 2008-05-29 | Cv Therapeutics, Inc. | Use of a2a adenosine receptor agonists in the treatment of ischemia |
| US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
| RU2459626C2 (ru) * | 2006-09-01 | 2012-08-27 | Гайлид Сайэнсиз, Инк. | Способы и композиции, повышающие переносимость пациентом методов визуализации миокарда |
| US20080170990A1 (en) * | 2006-09-29 | 2008-07-17 | Cv Therapeutics, Inc. | Methods for Myocardial Imaging in Patients Having a History of Pulmonary Disease |
| JP2010515081A (ja) * | 2007-01-03 | 2010-05-06 | ギリアード・パロ・アルト・インコーポレイテッド | 心筋灌流画像化 |
| AU2009296235A1 (en) * | 2008-09-29 | 2010-04-01 | Gilead Sciences, Inc. | Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5134443B2 (de) * | 1972-10-09 | 1976-09-27 | ||
| JPS5140134B2 (de) * | 1972-12-27 | 1976-11-01 | ||
| JPS50142595A (de) * | 1974-05-14 | 1975-11-17 | ||
| JPS6299395A (ja) * | 1985-10-25 | 1987-05-08 | Yamasa Shoyu Co Ltd | 2−アルキニルアデノシンおよび抗高血圧剤 |
| EP0444196B1 (de) * | 1988-11-15 | 1994-06-08 | Yamasa Shoyu Kabushiki Kaisha | Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen |
| ES2077070T3 (es) * | 1989-06-20 | 1995-11-16 | Yamasa Shoyu Kk | Intermedio de sintesis de 2-alquiniladenosina, produccion de dicho intermedio, produccion de 2-alquiniladenosina a partir de dicho intermedio, y derivado de 2-alquiniladenosina estable. |
| JPH095526A (ja) * | 1995-06-14 | 1997-01-10 | Asahi Glass Co Ltd | 重畳型ホログラム |
-
1991
- 1991-02-12 JP JP3040894A patent/JP2740362B2/ja not_active Expired - Fee Related
-
1992
- 1992-02-07 CA CA002060865A patent/CA2060865C/en not_active Expired - Fee Related
- 1992-02-10 EP EP92102210A patent/EP0499185B1/de not_active Expired - Lifetime
- 1992-02-10 DE DE69202483T patent/DE69202483T2/de not_active Expired - Fee Related
- 1992-02-10 ES ES92102210T patent/ES2073793T3/es not_active Expired - Lifetime
- 1992-02-10 AT AT92102210T patent/ATE122680T1/de not_active IP Right Cessation
- 1992-02-11 US US07/833,718 patent/US5939543A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69202483D1 (de) | 1995-06-22 |
| DE69202483T2 (de) | 1995-09-28 |
| JP2740362B2 (ja) | 1998-04-15 |
| ES2073793T3 (es) | 1995-08-16 |
| US5939543A (en) | 1999-08-17 |
| EP0499185A1 (de) | 1992-08-19 |
| CA2060865C (en) | 2000-05-16 |
| JPH05194579A (ja) | 1993-08-03 |
| CA2060865A1 (en) | 1992-08-13 |
| EP0499185B1 (de) | 1995-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE122680T1 (de) | Stabil fest 2-octynyladenozin und verfahren zu ihrer herstellung. | |
| DE68919341D1 (de) | Verfahren zur Herstellung von Fasern aus Polyvinylalkohol- Zusammensetzungen. | |
| FI854869A0 (fi) | Foerfarande foer framstaellning av foerbaettrad kakao. | |
| ATE311748T1 (de) | Modifizierte formen des natamycins, verfahren zu ihrer herstellung und sie enthaltende antifungale zusammensetzungen | |
| DE3580293D1 (de) | Ungesaettigte amido-substituierte cyclische aethern-verbindungen und verfahren zu ihrer herstellung. | |
| DE59203191D1 (de) | Bauteilsatz zur Herstellung einer Verpackung. | |
| DE3889393D1 (de) | Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen. | |
| ATE161545T1 (de) | Stärke mit geringem gehalt an amylopektin | |
| ATE122367T1 (de) | Eine feuchtigkeitshärtende einkomponenten- polysiloxanzuzammensetzung. | |
| DE59003144D1 (de) | Destillationsanlage zur Herstellung von Wasserstoff-Peroxid. | |
| DE68902192D1 (de) | Ethylenthioharnstoff enthaltende zusammensetzungen zur herstellung von verschleissfesten, stromlos abgeschiedenen nickel-borueberzuegen. | |
| DE3581524D1 (de) | Verfahren zur herstellung von papieraehnlichen produkten aus polymerbehandelten fasern. | |
| HUP9802956A2 (hu) | Gyöngykorom és eljárás előállítására | |
| FR2514766B1 (fr) | Nouveaux derives de 1,2,4-triazole et leurs applications comme produits fongicides | |
| EP0192713A4 (de) | Xenocoumacine. | |
| ATE111120T1 (de) | Glutaraldehydharz-verbindungssystem für herstellung von holzprodukten. | |
| DE3885720D1 (de) | Verfahren zur Herstellung von 4-Amino-1,2,4-triazol-5-onen. | |
| DE3788908D1 (de) | Verfahren zur Herstellung von Zuckern aus Stärke. | |
| DE69200653D1 (de) | Verfahren zur Herstellung von Matrizen. | |
| FR2688510B1 (fr) | Compositions polymeres contenant des phosphites ou phosphonites comme stabilisants. | |
| DE59201325D1 (de) | Verbessertes Verfahren zur Herstellung von Polyenen. | |
| DE59106456D1 (de) | Verfahren zur Herstellung von linearen 1,3-Diketonen. | |
| FI811490A7 (fi) | Kemiallisten yhdisteiden seos, joka on erityisesti tarkoitettu selluloosakuituja tai sentapaisia sisältävien tai niistä muodostettujen tuotteiden, kuten tekstiilien, mattojen, levyjen yms. käsittelyyn niiden palonkestävyyden parantamiseksi sekä.. | |
| PT82195A (de) | Einrichtung zur herstellung von mineralfasern aus silikatischen rohstoffen wie basalt insbesondere nach dem duesenblasverfahren | |
| DE59300178D1 (de) | Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |